Effect of Lysine, Vitamin B6, and Carnitine Supplementation on the Lipid Profile of Male Patients With Hypertriglyceridemia: A 12-Week, Open-Label, Randomized, Placebo-Controlled Trial

Clinical Therapeutics

Volumn 34, Issue 8, 2012, Pages 1674-1682

  Hlais, Sani ^a   Reslan, Dana R Abou ^a   Sarieddine, Hiba K ^a   Nasreddine, Lara ^a   Taan, Ghazi ^b   Azar, Sami ^a   Obeid, Omar A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Directorate of Health and Social Services   (Lebanon)

Author keywords

Carnitine; Hypertriglyceridemia; Lipid profile; Lysine; Vitamin B6

Indexed keywords

CARNITINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSINE; PLACEBO; PYRIDOXINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARNITINE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; LEBANON; LIPIDS; LYSINE; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; VITAMIN B 6;

EID: 84864594124     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2012.06.019     Document Type: Article

References (34)

1. Pejic R.N., Lee D.T. Hypertiglyceridemia. Heart 2006, 92:1529-1539.
2. Yuan G., Al-Shali K.Z., Hegel R.A. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007, 176:1113-1120.
3. Brady P.S., Brady L.J. Hepatic carnitine palmitoyltransferase turnover and translation rates in fed, starved, streptozotocin-diabetic and diethylhexyl phthalate-treated rats. Biochem J 1987, 246:641-649.
4. Vaz F.M., Wanders R.J. Carnitine biosynthesis in mammals. Biochem J 2002, 361:417-429.
5. Gropper S.S., Smith J.L., Groff J.L. Advanced Nutrition and Human Metabolism 2005, Wadsworth. 4th ed.
6. Hatchcock J.N., Shao A. Risk assessment for carnitine. Regul Toxicol Parmacol 2006, 46:23-28.
7. Krajcovicova-Kudlackova M., Simoncic R., Bederova A., et al. Correlation of carnitine levels to methionine and lysine intake. Physiol Res 2000, 49:399-402.
8. Tanphaichitr V., Zaklama M.S., Broquist H.P. Dietary lysine and carnitine: relation to growth and fatty livers in rats. J Nutr 1976, 106:111-117.
9. Khan L., Bamji M.S. Tissue carnitine deficiency due to dietary lysine deficiency: triglyceride accumulation and concomitant impairment in fatty acid oxidation. J Nutr 1979, 109:24-31.
10. Tome D., Bos C. Lysine requirement through the human life cycle. J Nutr 2007, 137:1642S-1645S.
11. Pellett P.L., Ghosh S. Lysine fortification: past, present, and future. Food Nutr Bull 2004, 25:107-113.
12. Cho Y.O., Leklem J.E. In vivo evidence for a vitamin B6 requirement in carnitine synthesis. J Nutr 1990, 120:258-265.
13. Dunn W.A., Aronson N.N., Englard S. The effects of 1-amino-D-proline on the production of carnitine from exogenous protein-bound trimethyllysine by the perfused rat liver. J Biol Chem 1982, 257:7948-7951.
14. Chen W., Huang Y., Shultz T.D., Mitchell M.E. Urinary, plasma, and erythrocyte carnitine concentrations during transition to a lactoovovegetarian diet with vitamin B-6 depletion and repletion in young adult women. Am J Clin Nutr. 1998, 67:221-230.
15. Mehio Sibai A., Obeid O., Batal M., et al. Prevalence and correlates of metabolic syndrome in an adult Lebanese population. CVD Prevention and Control 2008, 3:83-90.
16. Obeid O., Khatib L., Batal M., et al. Established and suspected biomarkers of cardiovascular disease risk in pre-menopausal Lebanese women. Ecology of Food and Nutrition 2008, 47:298-311.
17. Food and Agriculture Organization of the United Nations. FAO Statistics Division, 2008, Accessed January 23, 2008. http://faostat.fao.org/site/502/DesktopDefault.aspx?PageID=502.
18. Godsland I.F., Crook D., Simpson R., et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990, 323. 1375-1338.
19. Harripersad R., Burger F.J. The effect of a subnormal dose of vitamin B6 on plasma lipid in the rat. Int J Vitam Nutr Res 1997, 67:95-101.
20. Brattstrm̈ L., Stavenow L., Galvard H., et al. Pyridoxine reduces cholesterol and increases antithrombin III activity in 80-year-old men with low plasma pyridoxal-5-phosphate. Scan J Clin Lab Invest. 1990, 50:873-877.
21. Pregnolato P., Maranesi M., Marchetti M., et al. Interaction among dietary vitamin B6, proteins and lipids: effects on liver lipids in rats. Int J Vitam Nutr Res 1994, 64:263-269.
22. Dionyssiou-Asteriou A., Triantafyllou A., Lekakis J., Kalofoutis A. Influence of prostaglandin E1 on high density lipoprotein-fraction lipid levels in rats. Biochem Med Metab Biol 1986, 36:114-117.
23. Shepard D.C., Hitz J.B., Dain J.A. Pyridoxal-5'-phosphate inhibits non-enzymatic glycosylation of proteins. Biochem Arch 1985, 1:143-151.
24. Brownlee M., Vlassara H., Cerami A. Inhibition of heparin-catalyzed hyman antithrombin III activity by nonenzymatic glycosylation: possible role of fibrin deposition in diabetes. Diabetes 1984, 33:532-535.
25. Gonen B., Baenziger J., Schonfeld G., et al. Nonenzymatic glycosylation of low density lipoproteins in vitro: effects on cell-interactive properties. Diabetes 1981, 30:875-878.
26. Tully D.B., Allgood V.E., Cidlowski J.A. Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB J 1994, 8:343-349.
27. Peeke P.M., Chrousos G.P. Hypercortisolism and obesity. Ann N Y Acad Sci 1995, 771:655-676.
28. Haffner S.M., Mykkanen L., Valdez R., Katz M.S. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metab 1993, 77:1610-1615.
29. Derosa G., Cicero A.F., Gaddi A., et al. The effect of L-carnitine on plasma lipoprotein (a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 2003, 25:1429-1439.
30. Rahbar A.R., Shakerhosseini R., Saadat N., et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 2005, 59:592-596.
31. Sulochana K.N., Lakshmi S., Punitham R., et al. Effect of oral supplementation of free amino acids in type 2 diabetic patients-a pilot clinical trial. Med Sci Monit 2002, 8:CR132-C137.
32. Kalogeropoulou D., LaFave L., Schweim K., et al. Lysine ingestion markedly attenuates the glucose response to ingested glucose without a change in insulin response. Am J Clin Nutr 2009, 90:314-320.
33. Iritani N., Sugimoto T., Fukuda H. Soybean increases insulin receptor gene expression in fatty rats when polyunsaturated fatty acid level is low. J Nutr 1997, 127:1077-1083.
34. Sulochana K.N., Rajesh M., Ramakrishnan S. Improved insulin receptor tyrosine kinase activity in monocytes of type 2 diabetes mellitus patients receiving oral L-lysine as supplement. Ind J Bioch Biophy 2001, 18:277-282.